200 Participants Needed

Exercise Intensity for Cardiorespiratory Fitness

(REVISE Trial)

RR
Overseen ByRobert Ross, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Robert Ross, PhD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores how various exercise types affect cardiorespiratory fitness and overall heart health. Researchers aim to determine whether increasing exercise frequency or intensity benefits everyone or if some individuals see no improvement. Participants will join groups with different exercise routines, ranging from low to high intensity and duration. Individuals with a sedentary lifestyle (exercising once a week or less), stable weight, and a BMI between 20 and 40 may be suitable for this trial. The goal is to identify whether some people require alternative strategies beyond standard exercise guidelines. As an unphased trial, this study provides a unique opportunity to enhance understanding of personalized exercise strategies for improved heart health.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research shows that high-intensity interval training (HIIT) is generally safe and most people tolerate it well. Studies have found that HIIT can enhance exercise capacity and improve heart and lung health without causing major problems. The dropout rate from these studies is about 23%, indicating that most participants manage this type of exercise.

For those engaging in low-intensity exercise, current research suggests it's safe and beneficial for improving heart and lung health. Even short exercise sessions, like 10 to 15 minutes, can be effective and reduce health risks.

Overall, past research has shown that different levels of exercise intensity and duration in this study are safe. Always consult a healthcare provider before starting any new exercise program, especially if existing health issues are present.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores how varying amounts and intensities of exercise can boost cardiorespiratory fitness. Unlike typical exercise recommendations that often suggest moderate activity, this trial dives into the effects of high-intensity workouts in different doses. By understanding how these different exercise regimens impact fitness, the trial aims to uncover more personalized and effective exercise strategies. This could lead to new guidelines that optimize heart and lung health for people with diverse fitness levels and needs.

What evidence suggests that this trial's exercise treatments could be effective for improving cardiorespiratory fitness?

Research shows that high-intensity interval training (HIIT), experienced in this trial as either a high or low amount, greatly improves heart and lung fitness in adults. Studies have found that both high and low amounts of HIIT enhance fitness more than regular moderate exercise or no exercise. In this trial, some participants will engage in low-amount, low-intensity exercise, which evidence suggests can still reduce the risk of heart disease. This indicates that any regular exercise, whether intense or not, can improve heart and lung health. Overall, exercising regularly, regardless of intensity, positively impacts fitness and health.36789

Who Is on the Research Team?

RR

Robert Ross, PhD

Principal Investigator

Queen's University

Are You a Good Fit for This Trial?

This trial is for adults who lead a sedentary lifestyle, exercising no more than once a week, have had a stable weight for the past 6 months, and have a BMI between 20-40. It's not suitable for individuals with diabetes, current smokers, those planning to move soon or anyone with physical impairments that make exercise difficult or unsafe.

Inclusion Criteria

You do not engage in physical activity more than once a week.
Your body mass index (BMI) falls between 20 and 40 kg/m2.
Weight stable (± 2 kg) for 6 months prior to the beginning of the study

Exclusion Criteria

Plan to move from the area in next 8 months
Physical impairment which would make the intervention very difficult or unsafe according to doctor's advice
I have diabetes and I currently smoke.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

First Line Therapy

Participants engage in 150 minutes per week of moderate physical activity (MPA) for 16 weeks to assess initial response in cardiorespiratory fitness (CRF) and cardiometabolic risk factors.

16 weeks
4 visits (in-person) every 4 weeks

Increased Exercise Intensity/Amount

Participants who do not respond to first line therapy increase exercise intensity or amount for an additional 16 weeks to evaluate changes in CRF and cardiometabolic risk factors.

16 weeks
4 visits (in-person) every 4 weeks

Follow-up

Participants are monitored for safety and effectiveness after the exercise intervention phases.

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • High amount, high intensity exercise
  • Low amount, high intensity exercise
  • Low amount, low intensity exercise
Trial Overview The study is testing how different amounts and intensities of exercise affect cardiorespiratory fitness and cardiometabolic risk factors. Participants will be assigned to one of three groups: low amount/low intensity exercise, low amount/high intensity exercise, or high amount/high intensity exercise.
How Is the Trial Designed?
4Treatment groups
Experimental Treatment
Active Control
Group I: Low amount, low intensity exerciseExperimental Treatment1 Intervention
Group II: Low amount, high intensity exerciseExperimental Treatment1 Intervention
Group III: High amount, high intensity exerciseExperimental Treatment1 Intervention
Group IV: ControlActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Robert Ross, PhD

Lead Sponsor

Robert Ross, PhD

Lead Sponsor

Queen's University

Lead Sponsor

Trials
382
Recruited
122,000+

Published Research Related to This Trial

In a study involving 17 inactive obese males, a single session of high-intensity interval exercise (HIIE) and moderate-intensity continuous exercise (MICE) did not lead to significant changes in overall physical activity or sedentary behavior levels over the following week.
Both types of exercise can be safely incorporated into the routines of inactive obese males without negatively impacting their daily activity levels or increasing sedentary time.
Effects of High-Intensity Interval and Moderate-Intensity Continuous Exercise on Physical Activity and Sedentary Behavior Levels in Inactive Obese Males: A Crossover Trial.Santos, VOA., Browne, RAV., Souza, DC., et al.[2020]
In a study of 36 male cyclists and triathletes, the individual anaerobic threshold (IAT) was found to be closely aligned with exercise intensities defined as 75% of VO2max and 85% of HRmax, indicating that these measures can be effective for assessing exercise intensity.
However, the study revealed significant variability in how VO2max and HRmax correspond to the IAT, suggesting that using these parameters alone may not accurately reflect physiological responses during exercise, especially at lower intensities.
Is determination of exercise intensities as percentages of VO2max or HRmax adequate?Meyer, T., Gabriel, HH., Kindermann, W.[2022]
High-intensity interval training (HIIT) is as effective, if not more so, than traditional moderate-intensity continuous training (MICT) for patients with cardiovascular disease, based on a systematic review of 23 studies involving 1117 participants.
The safety profile of HIIT in cardiac rehabilitation is promising, with only one major cardiovascular adverse event reported per 17,083 training sessions, indicating that HIIT can be safely implemented in this population.
High-Intensity Interval Training for Patients With Cardiovascular Disease-Is It Safe? A Systematic Review.Wewege, MA., Ahn, D., Yu, J., et al.[2021]

Citations

1.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/38760916/
An umbrella review of systematic reviews and meta-analysesExisting evidence from systematic reviews consistently supports the effect of HIIT on enhancing CRF in adults when compared to non-exercise control and MICT.
High‐intensity interval training and cardiorespiratory fitness ...The majority of reviews indicated that HIIT results in similar or greater improvements in CRF when compared with MICT and other exercise ...
Effects of high-intensity interval training on physical fitness ...Furthermore, the findings indicate that HIIT significantly enhances cardiorespiratory fitness and reduces body fat percentage, even in ...
High-intensity interval training improves respiratory and ...Results: HIIT significantly improved not only maximal oxygen uptake and minute ventilation, but also maximal heart rate (HR), systolic blood ...
The effectiveness of a high-intensity interval exercise on ...Considering the literature, HIIT significantly improves cardiorespiratory fitness (V̇O₂peak), body composition, and metabolic parameters such as ...
Evidence-Based Effects of High-Intensity Interval Training on ...Research has indicated that high-intensity interval training induces numerous physiological adaptations that improve exercise capacity.
Can high-intensity interval training improve health ...HIIT may improve cardiorespiratory fitness and reduce drug craving in this population. The pooled dropout rate is 23.08%, with only two dropout cases being ...
Cardiorespiratory Fitness Benefits of High-Intensity Interval ...Results have been promising, suggesting that HIIT may be superior for improving mobility, with the greatest gains in V̇O2peak achieved after long ...
Massive study uncovers how much exercise is needed to ...Participants who performed two to four times above the recommended amount of moderate physical activity had a 26% to 31% lower all-cause mortality and a 28% to ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security